A Phase Ⅱ Study of F520 in Patients With Urothelial Carcinoma

Clinical trial NCT04636515 · UNKNOWN

Trial details

NCT number: NCT04636515
Sponsor: Shandong New Time Pharmaceutical Co., LTD
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Urothelial Cell Carcinoma

Start date: 2021-01-01
Primary completion: 2022-03-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.